More than 90% of cases of diabetes in humans correspond to the type 2 diabetes (T2D) variety, a condition characterized by deficient insulin secretion by pancreatic β-cells, tissue insulin resistance (IR), and an inadequate compensatory insulin secretory response [1]. This evidence concerns the gene INS and type 2 diabetes mellitus.